Radiotherapy News and Research

RSS

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

18 Jun 2015

Identifying obstructive coronary artery disease in women: an interview with Dr. Ladapo, NYU School of Medicine

A recent study presented at the American College of Cardiology 64th Annual Scientific Meeting evaluated the impact of an age, sex, and gene expression score on clinical decision-making and the rate of further cardiac evaluation in symptomatic female patients suggestive of CAD in the outpatient setting.

17 Jun 2015

Loyola tests new combination treatment for people living with cancer that has spread to spine

Loyola University Medical Center is the first center in the country to enroll patients in a clinical trial of a minimally invasive treatment for patients living with cancer that has spread to the spine.

17 Jun 2015

Varian selected to equip, service HollandPTC in Delft with ProBeam proton therapy system

Varian Medical Systems today announced that it has been selected to equip and service the new multi-room HollandPTC in Delft with the Varian ProBeam proton therapy system. The company will book the equipment part of the order in its fiscal 2015 third quarter.

3 Jun 2015

New article published in Spanish Journal of Pathology highlights a rare case of Hodgkin's lymphoma

Dr. Jerónimo Forteza, Professor of Pathology and Director of the Valencian Institute of Pathology, Catholic University of Valencia "San Vicente Mártir," recently published an article in the Spanish Journal of Pathology on the case of a patient with Hodgkin's lymphoma. Medicine student Pablo Sánchez Vela performed this diagnostic work under the supervision of Dr. Forteza.

3 Jun 2015

Apatorsen added to first-line chemotherapy benefits metastatic bladder cancer patients

OncoGenex Pharmaceuticals, Inc. announced that results from an exploratory analysis of the Phase 2 Borealis-1 trial showed that metastatic bladder cancer patients with poor prognostic features benefited from apatorsen 600mg added to first-line chemotherapy compared to chemotherapy alone.

2 Jun 2015

DNA Therapeutics to present DT01 phase 1/2a trial results at ASCO 2015

DNA Therapeutics, a private biopharmaceutical company developing DT01, a first-in-class clinical pan DNA repair inhibitor to treat tumors resistant to conventional treatments, will today present the results of the first-in-man phase 1/2a trial of DT01 in combination with radiation therapy in patients with cutaneous metastatic melanoma.

2 Jun 2015

Helsinn launches Helsinn Integrative Care division at ASCO Annual Meeting

Helsinn, the Swiss Group focused on building quality cancer care, announces today that its recently launched Helsinn Integrative Care division is meeting the cancer community at booth 6033 at the American Society of Clinical Oncology Annual Meeting, May 29-June 2, Chicago, Illinois.

2 Jun 2015

Mount Sinai Health System researchers present updates on cancer vaccine clinical trials at ASCO 2015

Mount Sinai Health System faculty will be presenting research updates on a lymphoma vaccine clinical trial, the best dosing for a drug against metastatic cancer, and new treatment strategies in relapsed multiple myeloma at the American Society of Clinical Oncology annual meeting, May 29 - June 2, 2015, in Chicago.

2 Jun 2015

Adding AKT inhibitors to radiotherapy could be effective for treating many cancers

Cancer Research UK scientists have discovered how giving a class of drugs called AKT inhibitors in combination with radiotherapy might boost its effectiveness across a wide range of cancers, according to a study published in the Journal of Clinical Investigation today.

1 Jun 2015

Acupuncture-like TENS may be effective for treating radiation-induced xerostomia

Phase III results of Radiation Therapy Oncology Group 0537 indicate that acupuncture-like, transcutaneous electrical nerve stimulation (ALTENS) may be equally effective as pilocarpine, the current prescription medication in a pill, to treat radiation-induced xerostomia (dry mouth), according to a study published in the June 1, 2015 issue of the International Journal of Radiation Oncology * Biology * Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology.

30 May 2015

Hodgkin's lymphoma treatment can cause late sequelae

Hodgkin's lymphoma--cancer of the lymph nodes--arises in more than 150 children and adolescents in Germany each year. Nine out of ten patients survive the disease, thanks to the highly effective treatments that are now available. Depending on the type of treatment given, however, there may be late sequelae, as discussed by Wolfgang Dörffel and colleagues in an original article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2015; 112: 320-7).

29 May 2015

Varian, Flatiron Health partner to develop next generation of cloud-based software for cancer care providers

Varian Medical Systems and Flatiron Health today announced a strategic alliance to develop the next generation of cloud-based, electronic health record (EHR), data analytics and decision support software for cancer care providers around the world.

26 May 2015

Researchers discover new gene subgroup that drives prostate cancer

Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.

26 May 2015

nTMS analysis of motor areas improves prognosis of patients with malignant brain tumors

A method known as navigated transcranial magnetic stimulation (nTMS) has been gaining importance in neurosurgery for some time now.

22 May 2015

Stereotactic body radiotherapy appears to be safe, effective for some pancreatic cancer patients

Two studies from Johns Hopkins Kimmel Cancer Center researchers add to preliminary evidence that high-dose radiation treatment, called stereotactic body radiotherapy, appears to be safe and as effective as standard radiation treatment for certain patients with pancreatic cancer whose tumors are advanced but have not spread.

20 May 2015

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and targeted drug delivery, and DNAtrix Inc., a privately held biotechnology company and a leader in oncolytic virus therapy, have entered into an exclusive clinical collaboration. Under the agreement, DNAtrix will utilize Alcyone's MEMS Cannula (AMC) targeted delivery platform for the intratumoral delivery of DNX-2401, an oncolytic adenovirus and DNAtrix's lead product for the treatment of the most aggressive form of brain cancer, glioblastoma (GBM).

19 May 2015

U.K Ophthalmologists lead in treatment of wet AMD patients with Oraya therapy across europe

Oraya Therapy was introduced first in the U.K., followed by Switzerland and Germany. The therapy is intended as a one-time, non-invasive treatment that maintains vision with fewer anti-vascular endothelial growth factor (anti-VEGF) injections into the eye...

19 May 2015

Active surveillance appears to be safer management strategy for prostate cancer patients

Four studies evaluating effectiveness, trends and other considerations for active surveillance in managing prostate cancer will be presented during the 110th Annual Scientific Meeting of the American Urological Association.

17 May 2015

Patients with operable early-stage NSCLC could achieve better overall survival rates with SABR

Patients with operable stage I non-small cell lung cancer (NSCLC) could achieve better overall survival rates if treated with Stereotactic Ablative Radiotherapy (SABR) rather than the current standard of care -- invasive surgery -- according to research from a phase III randomized international study from The University of Texas MD Anderson Cancer Center.

15 May 2015

Radiotherapy News and Research

Further Reading

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

Identifying obstructive coronary artery disease in women: an interview with Dr. Ladapo, NYU School of Medicine

Loyola tests new combination treatment for people living with cancer that has spread to spine

Varian selected to equip, service HollandPTC in Delft with ProBeam proton therapy system

New article published in Spanish Journal of Pathology highlights a rare case of Hodgkin's lymphoma

Apatorsen added to first-line chemotherapy benefits metastatic bladder cancer patients

DNA Therapeutics to present DT01 phase 1/2a trial results at ASCO 2015

Helsinn launches Helsinn Integrative Care division at ASCO Annual Meeting

Mount Sinai Health System researchers present updates on cancer vaccine clinical trials at ASCO 2015

Adding AKT inhibitors to radiotherapy could be effective for treating many cancers

Acupuncture-like TENS may be effective for treating radiation-induced xerostomia

Hodgkin's lymphoma treatment can cause late sequelae

Varian, Flatiron Health partner to develop next generation of cloud-based software for cancer care providers

Researchers discover new gene subgroup that drives prostate cancer

nTMS analysis of motor areas improves prognosis of patients with malignant brain tumors

Stereotactic body radiotherapy appears to be safe, effective for some pancreatic cancer patients

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

U.K Ophthalmologists lead in treatment of wet AMD patients with Oraya therapy across europe

Active surveillance appears to be safer management strategy for prostate cancer patients

Patients with operable early-stage NSCLC could achieve better overall survival rates with SABR

Cancer Research - Second Edition eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News